The Filing Desk

Accuray vs MiMedx Group

Accuray ARAY · MiMedx Group MDXG · Health Care Equipment

MiMedx Group reported revenue of $419 million in fiscal 2025, about the same as Accuray's $402 million in fiscal 2026. Accuray's revenue fell 12.3% in its latest year, and MiMedx Group's grew 20.0%. Accuray had an operating margin of -6.6%, against 15.3% at MiMedx Group. Their fiscal years end in different months (June 30 and December 31), so the periods don't line up exactly.

Side by side

AccurayMiMedx Group
Latest fiscal yearFY2026, Jun 30, 2026FY2025, Dec 31, 2025
Revenue$402M$419M
Revenue growth−12.3%20.0%
Revenue growth a year, last 5 years0.3%11.0%
Gross margin27.7%82.6%
Operating margin−6.6%15.3%
Net margin−12.2%11.6%
Free cash flow−$13M—
Free cash flow margin−3.2%—
Return on capital—43.3%
Net debt to EBITDA—−1.9x
Dividends and buybacks$0M$0M
Change in diluted share count19.3%0.5%
Last close$2.12$3.11
P/E at the last close——
Insider trades, last 12 monthsbought $134,146, sold $0—
Piotroski F-score—7 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AccurayMiMedx Group
Operating margin
Percent of revenue
AccurayMiMedx Group
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AccurayMiMedx Group

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Accuray and MiMedx Group pages.